Apollo Hospitals Q1FY25: Revenue jumps 15%, PAT 83%

Apollo Hospitals Group announced the financial results for the first quarter of FY2025.

Consolidated revenue jumped 15 percent YoY to Rs. 5,086 crore in Q1FY 25.

Consolidated EBITDA jumped 33 percent to Rs.675 crore in Q1FY 25

Reported PAT jumped 83 percent to Rs. 305 crore, compared to Rs. 167 crore in Q1 FY24.

“Apollo Hospitals has consistently strived to enhance the quality of healthcare delivery, as demonstrated by our flagship facility in Chennai receiving its seventh consecutive accreditation from JCI. This achievement highlights our dedication to patient safety, quality care, and effective leadership, aligning with our commitment to world-class healthcare as our core growth driver. We continue to lead the industry in adopting and implementing best-in-class healthcare solutions and technologies to push the boundaries of healthcare for better patient outcomes. Our experts have achieved significant milestones, such as performing India’s first Robotic Cytoreductive Surgery, introducing the CORI Surgery System for joint replacements, and conducting the first TRIC Valve Procedure in a patient with two prosthetic valves in India. We are also championing efforts to counter the growing menace of non-communicable diseases (NCDs) in India,” said Dr. Prathap C. Reddy, Chairman, Apollo Hospitals Group.

“This year’s ‘Health of the Nation’ report indicates that India is on the verge of becoming the cancer capital of the world. We are committed to tackling NCDs through an integrated approach driven by our leading experts and supported by technological innovations, aiming to reduce their impact and enhance patient outcomes. In the first quarter of FY25, we have seen significant growth and improved the reach of our retail operations. As we continue our growth journey, we remain dedicated to advancing healthcare excellence, implementing innovative solutions, and improving access to the best healthcare services throughout India and beyond.”
MB Bureau